All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
DUBLIN – Will tempol, a tool compound long used for its intracellular antioxidant effects, prove to be of clinical benefit to patients with cerebral cavernous malformation (CCM)?
